If you are not a good candidate for GLP-1 agonists, our providers will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools
The broader receptor activity of tirzepatide may contribute to slightly higher rates of early gastrointestinal intolerance, although discontinuation rates remain comparable 7
Retatrutide is being studied as a triple-receptor medication that targets GIP, GLP-1, and glucagon receptors
For effective weight loss, the target dose is 2.4 mg weekly , reached after the initial 16-week titration period
Patent Information: 2026 Novo Nordisk Medication Guide SPL MEDGUIDE SECTION MEDICATION GUIDE WEGOVY (wee-GOH-vee) (semaglutide) injection, for subcutaneous use WEGOVY (wee-GOH-vee) (semaglutide) tablets, for oral use Do not share your pen, Wegovy FlexTouch or needles with other people, even if the needle has been changed
Understanding how Semaglutide interacts with your bodys hunger signals is the first step toward achieving sustainable, long-term health outcomes
